Semaglutide News and Research

Latest Semaglutide News and Research

Treating obesity using glucagon-like peptide-1-directed N-methyl-D-aspartate receptor inhibition

Treating obesity using glucagon-like peptide-1-directed N-methyl-D-aspartate receptor inhibition

New therapy shows greater weight loss in mice by targeting brain's appetite center

New therapy shows greater weight loss in mice by targeting brain's appetite center

Anti-obesity medications slash heart disease risk in obese patients, study finds

Anti-obesity medications slash heart disease risk in obese patients, study finds

Technology alone insufficient for meaningful weight loss in obesity, study shows

Technology alone insufficient for meaningful weight loss in obesity, study shows

New study reveals brain clearance of toxins is reduced during sleep and anesthesia

New study reveals brain clearance of toxins is reduced during sleep and anesthesia

Semaglutide shows significant weight loss and health benefits in four-year obesity study

Semaglutide shows significant weight loss and health benefits in four-year obesity study

Sustainable weight loss with personalized semaglutide dosing

Sustainable weight loss with personalized semaglutide dosing

Social media channels could be harnessed to provide information about obesity to young people

Social media channels could be harnessed to provide information about obesity to young people

Semaglutide improves heart failure symptoms and reduces loop diuretic dose

Semaglutide improves heart failure symptoms and reduces loop diuretic dose

Aerobic exercise proves most effective for combating obesity-related inflammation

Aerobic exercise proves most effective for combating obesity-related inflammation

Enhanced weight loss outcomes with GLP-1 analogues and bupropion/naltrexone combination

Enhanced weight loss outcomes with GLP-1 analogues and bupropion/naltrexone combination

Innovative endoscopic treatment targets hunger hormone for weight loss

Innovative endoscopic treatment targets hunger hormone for weight loss

TIME reveals new list recognizing the 100 most influential individuals in health

TIME reveals new list recognizing the 100 most influential individuals in health

Metabolic health determines effectiveness of influenza vaccination

Metabolic health determines effectiveness of influenza vaccination

Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients

Phase 2 trial reveals Lixisenatide may reduce motor disability in Parkinson’s patients

Popular diabetes drugs not linked to thyroid cancer risk, study finds

Popular diabetes drugs not linked to thyroid cancer risk, study finds

Treating early-stage heart failure in diabetic patients: Insights from ARISE-HF trial

Treating early-stage heart failure in diabetic patients: Insights from ARISE-HF trial

Weight loss drugs associated with increased risk of aspiration pneumonia following endoscopy

Weight loss drugs associated with increased risk of aspiration pneumonia following endoscopy

AI-based analysis uncovers two plant extracts with potential as GLP-1 agonist weight loss pills

AI-based analysis uncovers two plant extracts with potential as GLP-1 agonist weight loss pills

Unlocking weight loss through exercise mimicry with metformin

Unlocking weight loss through exercise mimicry with metformin

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.